Evidence map›Paper›PMID 36321000›Full record

ArticleCureus2022

A Rare Case of Neuroendocrine Tumor in a Patient With Neurofibromatosis Type 1: Is There Any Association?

Fatima Zahra Baddi, Fatima Zohra Ahsayen, Hiba Ramdani, Meriem Rhazari, Imane Skiker, Afaf Thouil, Hatim Kouismi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fatima Zahra BaddiDepartment of Respiratory Diseases, Mohammed VI University Hospital, Oujda, MAR.
Fatima Zohra AhsayenDepartment of Radiology, Mohammed VI University Hospital, Oujda, MAR.
Hiba RamdaniDepartement of Medicine, Mohammed VI University Hospital, Oujda, MAR.
Meriem RhazariDepartment of Respiratory Diseases, Mohammed VI University Hospital, Oujda, MAR.
Imane SkikerDepartment of Radiology, Mohammed VI University Hospital, Oujda, MAR.
Afaf ThouilDepartment of Respiratory Diseases, Mohammed VI University Hospital, Oujda, MAR.
Hatim KouismiDepartment of Respiratory Diseases, Mohammed VI University Hospital, Oujda, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant condition characterized by café-au-lait spots, cutaneous neurofibromas, axillary and inguinal freckling, and iris Lisch nodules; however, the presentations vary greatly, even within families. NF1 is also a recognized risk factor for the development of malignancy particularly malignant peripheral nerve sheath tumors (MPNST), optic gliomas, other gliomas, and leukemia. Nevertheless, the occurrence of lung cancer in a patient with neurofibromatosis type 1 is a rare phenomenon. Here we present a case of neuroendocrine tumor in a patient with neurofibromatosis type 1, highlighting the association between the two diseases. This case report also aimed to raise awareness of possible malignancies in patients with neurofibromatosis type 1.

Indexed as

lung cancermalignanciesneuroendocrine tumorneurofibromatosis type 1 (nf1)risk factor

Identifiers

PMID36321000
PMCPMC9604765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.